Bank of America Corp DE Has $23.62 Million Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Bank of America Corp DE decreased its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 62.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,018,134 shares of the company's stock after selling 1,659,939 shares during the quarter. Bank of America Corp DE owned approximately 0.60% of Option Care Health worth $23,621,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP grew its position in shares of Option Care Health by 84.6% in the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after purchasing an additional 8,400,208 shares during the last quarter. Norges Bank acquired a new stake in shares of Option Care Health in the fourth quarter valued at about $60,219,000. Freestone Grove Partners LP acquired a new stake in shares of Option Care Health in the fourth quarter valued at about $17,487,000. Dimensional Fund Advisors LP grew its position in shares of Option Care Health by 17.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after purchasing an additional 591,042 shares during the last quarter. Finally, Victory Capital Management Inc. grew its position in shares of Option Care Health by 31.1% in the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock valued at $49,310,000 after purchasing an additional 503,840 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Option Care Health Price Performance

NASDAQ OPCH traded down $0.58 during trading on Friday, reaching $31.45. 289,139 shares of the company traded hands, compared to its average volume of 1,853,531. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock's 50 day moving average price is $33.05 and its two-hundred day moving average price is $29.24. The company has a market cap of $5.15 billion, a price-to-earnings ratio of 26.43, a P/E/G ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. Option Care Health's revenue was up 16.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.26 EPS. As a group, analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.64% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

OPCH has been the topic of several research analyst reports. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a research report on Tuesday, April 22nd. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and raised their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. JPMorgan Chase & Co. lifted their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Finally, Barrington Research reissued an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.